Thalidomide
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
Johns Hopkins University
Overview
Thalidomide is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Thalidomide clinical trials
Explore related
Medical disclaimer. This page summarizes research about Thalidomide for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.